Availability of fixed-dose, child-friendly formulations of first-line tuberculosis drugs in Europe

Antoni Noguera-Julian, Danilo Buonsenso, Lindsay McKenna, James A. Seddon, Nicole Ritz

Source: Eur Respir J, 58 (3) 2101196; 10.1183/13993003.01196-2021
Journal Issue: September
Disease area: Paediatric lung diseases, Respiratory infections

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Antoni Noguera-Julian, Danilo Buonsenso, Lindsay McKenna, James A. Seddon, Nicole Ritz. Availability of fixed-dose, child-friendly formulations of first-line tuberculosis drugs in Europe. Eur Respir J, 58 (3) 2101196; 10.1183/13993003.01196-2021

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: